Serum carbohydrate antigen 125 levels in advanced heart failure: Relation to B-type natriuretic peptide and left atrial volume

European Journal of Heart Failure

Volumn 10, Issue 6, 2008, Pages 556-559

  Duman, Dursun ^a   Palit, Fatih ^a   Simsek, Ergun ^a   Bilgehan, Karadag ^b  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Advanced heart failure; B type natriuretic peptide; Carbohydrate antigen 125; Left atrial volume

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HORMONAL REGULATION; HUMAN; MALE; PRIORITY JOURNAL;

AGED; CA-125 ANTIGEN; CARDIAC VOLUME; COHORT STUDIES; FEMALE; HEART ATRIA; HEART FAILURE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME;

EID: 44649149566     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.04.012     Document Type: Article

References (14)

1. Kouris N.T., Zacharos I.D., Kontogianni D.D., et al. The significance of CA 125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters. Eur J Heart Fail 7 (2005) 199-203
2. D'Aloia A., Faggiano P., Aurigemma G., et al. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis. J Am Coll Cardiol 41 (2003) 1805-1811
3. Nagele H., Bahlo M., Klapdor R., and Rödiger W. Tumor marker determination after orthotopic heart transplantation. J Heart Lung Transplant 18 (1999) 957-962
4. Nagele H., Bahlo M., Klapdor R., et al. Fluctuations of tumor markers in heart failure patients pre and post heart transplantation. Anticancer Res 19 (1999) 2531-2534
5. Nagele H., Bahlo M., Klapdor R., Schaeperkoetter D., and Rödiger W. CA 125 and its relation to cardiac function. Am Heart J 137 (1999) 1044-1049
6. Turk H.M., Pekdemir H., Buyukberber S., et al. Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid. Tumour Biol 24 (2003) 172-175
7. Faggiano P., D'Aloia A., Brentana L., et al. Serum levels of different tumour markers in patients with chronic heart failure. Eur J Heart Fail 7 (2005) 57-61
8. Simek C.L., Feldman M.D., Haber H.L., Wu C.C., Jayaweera A.R., and Kaul S. Relationship between left ventricular wall thickness and left atrial size comparison with other measures of diastolic function. J Am Soc Echocardiogr 8 (1995) 37-47
9. Douglas P.S. The left atrium. A biomarker of chronic diastolic dysfunction and cardiovascular disease risk. J Am Coll Cardiol 42 (2003) 1206-1207
10. Pritchett A.M., Jacobsen S.J., Mahoney D.W., Bailey R.J., Rodeheffer K.R., and Redfield M.M. Left atrial volume as an index of left atrial size a population based study. J Am Coll Cardiol 41 (2003) 1036-1043
11. Barclay J.L., Kruszewski K., Croal B.L., Cuthbertson B.H., Oh J.K., and Hillis G.S. Relation of left atrial volume to B-type natriuretic peptide levels in patients with stable chronic heart failure. Am J Cardiol 98 (2006) 98-101
12. Dodge H.T., Sandler H., Ballew D.W., and Lord Jr. D.J. The use of biplane angiocardiography for the measurements of left ventricular volumes in man. Am Heart J 60 (1960) 762-776
13. Deswal A., Petersen N.J., Feldman A.M., et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103 (2001) 2055-2059
14. Kosar F., Aksoy Y., Ozguntekin G., Ozerol I., and Varol E. Relationship between cytokines and tumour markers in patients with chronic heart failure. Eur J Heart Fail 8 (2006) 270-274